TrialGastroenterology2017

IFNL4 Genotype Is Associated With Virologic Relapse After 8-Week Treatment With Sofosbuvir, Velpatasvir, and Voxilaprevir.

Thomas R O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.